Turkey Fighting Uphill Battle In Pitch For Pharma, Medtech Investment
Executive Summary
Hoping to bring in more foreign investment and local production, Turkey is working hard to convince pharma and medtech companies of its attractions, but this effort is set to become even more challenging in the wake of the recent unsuccessful coup attempt and corporate worries over political instability.
You may also be interested in...
Turkey Restructures Reimbursement Body But Is It Enough?
Turkey has designated health sciences, and the pharmaceutical industry in particular, as a strategic sector to support economic development, and the government appears determined to turn the country into a regional hub by supporting production and high-value exports. The national reimbursement body has recently been restructured to promote these goals but the industry is cautious.
Medtech Procurement A Victim Of Turkey’s Ongoing Economic Troubles
The devaluation of the Turkish Lira since May is making imports of medical devices more expensive and putting hospital procurement under renewed pressure. The local medtech industry associations TUMDEF and ARTED describe the problems ̶ and the solutions ̶ to Medtech Insight.
A Bright Moment At Last In Turkish Medtech Debt Payments Saga
Turkish medtechs’ demands for payment of their outstanding hospital debts went unheeded in 2021, but the government has finally started a payment process. It is not evenly applied, and has started in a small way, but the industry feels encouraged on more than one count.